whatshot

LENZ   $3.915  5.24% Market Closed After Close 3.96 1.15%

LENZ Therapeutics, Inc.
show_chart Advanced Chart of LENZ

Current temperature: 5.27
ST: 0, Cor:

Analyst Recommendations:
Number of estimates 6
Target Price Mean 22.00
Mean unverified/preliminary 22.00 / 22.00
Target Price Low / High 7.00 / 60.00
Median / STD DEV 10.00 / 22.08
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total None Sell Sell
rsi Sell ActivelyBuy Sell
macd None Sell None
stoch Sell None None
ma20 Sell Sell None
ma50 None None None
ma100 None Sell Sell
Candlestick PatternSept. 24, 2026 Doji - is formed when the open and the close are the same or very close. The body of candle is small. The length of the shadows are not important. The appearance of a Doji should alert the investor of major indecision.
ISIN US52635N1037
ceo Mr. Evert B. Schimmelpennink
Website https://www.lenz-tx.com
LENZ Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing therapies to improve vision in the United States. Its product candidates include LNZ100 and LNZ101 which are in Phase III clinical trials for the treatment of presbyopia. The company is headquartered in Del Mar, California.